patocytes showed that ET-1 at subnanomolar concentrations induced a series of repetitive, sustained CaQ2 transients. ET-1 had no effect on cAMP production. Finally, ET-1 caused a rapid and sustained stimulation ofglycogenolysis in rat hepatocytes. A 1.8-fold maximal increase in glycogen phosphorylase a was observed at 1 pM ET-1, with an EC5" of 0.03 pM. Stimulation of the enzyme was specific for ET-1 since the order of potency of related peptides was similar to that in binding experiments (ET-1 > ET-3 > big ET-1). These data constitute the first demonstration of the presence of ET-1 binding sites in liver which is associated with a rise in cytosolic free Ca2' and a potent glycogenolytic effect. We conclude that ET-1 behaves as a typical Ca2+ mobilizing hormone in liver. (J. Clin. Invest.
Introduction
Endothelin-1 (ET-1)' is a potent vasoconstrictor peptide of 21 amino acid residues purified from the culture supernatant of porcine aortic endothelial cells (1) . ET-1 is synthesized as a 203 amino acid prepropeptide which is proteolytically cleaved to produce big ET-1 (1-38) (human) or (1-39) (porcine), and then processed to mature ET-1 (1-21) by a putative endothelin-converting enzyme (2, 3) . Two other types of endothelin genes are found in human genomic DNA, demonstrating the existence of three isoforms ofhuman endothelin, called ET-1, ET-2, and ET-3, with distinct structure and pharmacological activity (4). 1 . Abbreviations used in this paper: ET, endothelin.
Recently, the presence of a new peptide of the endothelin family has been also demonstrated in the mouse intestine (5) . In addition to its potent, long lasting vasoconstrictor and pressor actions, ET-1 has now been shown to exert a wide variety of biological activities in nonvascular tissues, including positive inotropic and chronotropic actions and stimulation of atrial natriuretic factor release in heart, inhibition of Na+/K' ATPase and renin release in kidney, stimulation ofaldosterone production in zona glomerulosa cells, mitogenic actions in fibroblasts, vascular smooth muscle cells and mesangial cells, and actions on the central nervous system and on neuronal excitability (for a review see reference 6 ). In agreement with these observations, autoradiographic experiments and immunoreactive studies have shown that specific high affinity binding sites for ET-1 and presence ofET-l-like immunoreactivity are localized not only in blood vessels but also in the peripheral tissues and central nervous system (7, 8) . We report here that ET-1 binds with a high affinity to rat liver plasma membranes, and demonstrate that ET-l binding to its sites induces sustained Ca2" mobilization and activation ofglycogenolysis in rat hepatocytes. This is the first demonstration that ET-1 behaves as a Ca2" mobilizing hormone in liver, where it exerts a major metabolic effect.
Methods
ET-I and ET-3 were purchased from Novabiochem Ltd. (UK). Big ET-1 Binding of'25I-ET-J to liver plasma membranes. Rat liver plasma membranes (10-20 ug/ml) were incubated for 90 min at 220C in a 200-jd Krebs-Ringer medium (pH 7.4) containing 20 mM Hepes, 1% (wt/vol) bovine serum albumin, 300 gg/ml bacitracin, and 60 pM '25I-ET-1. The incubation was stopped by adding 3 ml of ice cold KrebsRinger (pH 7.4), 20 mM Hepes buffer containing 1% (wt/vol) bovine serum albumin.
The contents of the assay tubes were filtered rapidly through Whatman GF/C filters presoaked in 1% polyethyleneimine then rinsed with 9 ml of ice cold wash buffer. The radioactivity ofthe filter was counted in an LKB multiwell gamma counter. Nonspecific binding was determined by incubating with 0.1 jIM unlabeled ET-1. Saturation experiments were performed with increasing concentrations of '251-ET-1 The association constant was determined by measuring the binding of 60 pM '251I-ET-1 to the liver plasma membranes at various times and dissociation was initiated after adding 0.2 ,uM unlabeled ET-1. Data from saturation, competition, and association experiments were analyzed using a nonlinear regression program ( 12) .
To assess the stability of '251-ET-1, the assay medium containing 60 pM '25I-ET-I and 10-20 jg/ml of liver plasma membranes was incubated under standard conditions at various times (0-90 min) at 22°C and filtered through 0.8 u Millex AA (Millipore Continental Water Systems, Bedford, MA). The '25I-ET-I in the resulting supernatants was analyzed by reverse-phase HPLC on a Synchropak RP-4 column (SynChrom, Inc., Linden, IN) using an 18-60% aqueous gradient of acetonitrile in 0.1% trifluoroacetic acid over 20 min at a 1 ml/min rate.
Aequorin measurements ofcytosolicfree Ca2+ in single rat hepatocytes. Measurements of cytosolic free Ca2+ were performed in single, aequorin-injected hepatocytes, as described before (13) . The experimental medium was Williams medium E (13) to which ET-1 was added.
Glycogen phosphorylase a assay and cAMP determination. Dilution of peptides were made in Hanks' medium containing 20 mM Hepes, pH 7.4, and 0.1 % BSA, and used immediately. Incubation ofrat hepatocytes (7-9.I06 cells/ml) with peptides was performed in a final volume of 100 uil for 90 s (except otherwise indicated) at 37°C, and stopped by quick freezing of the tubes in liquid nitrogen. The frozen tubes were kept at -80°C until use. For cAMP determinations, each 100-,ul aliquot of cells was diluted with an equal volume of 6% (vol/vol) trichloracetic acid. The resulting suspension was allowed to stand overnight at 4°C, then transferred to glass tubes and centrifuged at 1,500 g for 30 min at4C. cAMP determinations were performed in each supernatant by means of radioimmunoassays. For the measurement of glycogen phosphorylase a activity the frozen hepatocytes were homogenized according to Hue et (14) and Pi content was determined according to Kallner (17) .
Proteins. Membrane proteins were determined by the method of Bradford (18) with bovine serum albumin as standard.
Results
Binding of ET-J to rat liver plasma membranes. Binding of 125I-ET-I at 220C to rat liver membranes was time dependent (tj/2= 37+2 min; n = 3) and reached an apparent equilibrium at -90 min (kob, = 0.0 19±0.001 min-') ( Fig. 1) . Dissociation of receptor-bound ligand was minimal: only 5% ofdissociation was observed 5 h after the addition of 0.2 ,uM unlabeled ET-1 (Fig. 1 ). 19) , it was difficult to wash off ET-1 to terminate the free Ca2" response. In fact, ET-l caused a sustained response that lasted for at least 10 min (Fig. 4) .
Effects ofET-I on cyclic AMPproduction. Cyclic AMP was assayed after 2-and 5-min exposures to varying concentrations ofET-l from 5 pM to 5 nM and to 100 nM glucagon as control. As shown in Table I , while glucagon caused a threefold increase in cAMP levels, ET-l had no significant effect.
Effects ofET-I on glycogen phosphorylase a activity in hepatocytes. Incubation of hepatocytes with ET-1 resulted in a rapid and sustained activation ofglycogen phosphorylase a activity (Fig. 5) . min and persisted at least for 15 min. In contrast, the maximal increase in the enzyme activity induced by 10 nM glucagon was reached after 1 min and declined after 2 min. The effect of ET-1 on glycogen-phosphorylase a was dose dependent, and a maximal 1.8-fold was attained at 1 pM, half-maximal stimulation being observed for 0.03 pM ET-1 (Fig. 6 ). This degree of activation was comparable to the maximal twofold increase in the enzyme activity obtained with 100MuM epinephrine. (Fig. 6,  inset) . The specificity of the action of ET-1 was assessed on glycogen phosphorylase a using ET-3 and big ET-1. Both peptides were less active than ET-1, causing a maximal activation of 1.5-and 1.2-fold ofthe enzyme activity, at a final concentration of 100 pM. They were less potent than ET-l since halfmaximal activation was observed for 30 pM ET-3 and for 70 pM big ET-1 (Fig. 6 ).
Discussion
We report here that, in rat liver, ET-1 has specific receptors and is a typical Ca2" mobilizing hormone that induces activation of glycogenolysis. ET-1 receptors are a single class of high affinity and high capacity binding sites in rat liver plasma membranes, with an apparent Kd of 32.4 pM±9.8 pM, i.e., one order of magnitude higher than that reported in other tissues (20) (21) (22) (23) (24) (25) (26) , and a B__ of 1084+118 fmol/mg protein, comparable to the number of sites reported in aorta, lung, kidney, and brain (20, 27, 28) . Moreover, ET-3 discriminates between two ET-receptor subtypes on rat liver plasma membranes as recently reported in chick heart (29), rat lung (30) , and on rat vascular smooth muscle cells (31) . The binding for ET-I is specific and saturable within 90 min. The exceeding high affinity of the peptide for its receptor is also reflected by the low reversibility of ET-I binding (5% after 5 h; Fig. 1 ), even in the presence of PEPTIDE (-IoMW Figure 6 . Effects of ET-1, ET-3, big ET-1, and epinephrine on glycogen phosphorylase a activity. Hepatocytes (8.106 cells/ml) were incubated in a final volume of 100 Ml with varying concentrations of either' ET-I (-), ET-3 (i), big ET-1 (-), or epinephrine (inset) for 90 s at 370C. Glycogen (32) , kidney (27) , vascular smooth muscle cells (33, 23) , and adrenal glomerulosa cells (22) , and could explain the potent long lasting effect of this peptide (1, 6) . Elevation of intracellular free Ca2+ and not of cAMP has been invoked to mediate the action of ET-1; only in mesangial cells (34) and Swiss 3T3 fibroblasts (35) has a small increase (34) or decrease (35) in cAMP levels been reported in response to ET-1. Our results clearly show that ET-1 does not affect cAMP levels in rat hepatocytes (Table I) , but provokes oscillations in cytosolic free Ca2" in single aequorin-injected hepatocytes, similar to that produced by other Ca2+ mobilizing hormones (1 1, 19) . We have previously shown that the time course of the transients generated by an individual hepatocyte are characteristic of the stimulating agonist. Oscillations of free Ca2" induced by ET-l are reminiscent of those caused by vasopressin or angiotensin II, which evoke longer spikes than those observed with phenylephrine (1 1, 19) . However a particularity ofET-1-induced Ca2" transients is that the spikes lasted even after removing the peptide from the perfusion (Fig. 4) . The sustained elevation of intracellular free Ca2" in response to ET-1 has been observed in various tissues (36) (37) (38) (39) (40) , and is associated in hepatocytes with a long lasting activation of glycogenolysis (Fig. 5) . The effect of ET-1 on glycogen phosphorylase a is specific and the order of potencies of related peptides is similar in binding experiments (Fig. 3) and in glycogen phosphorylase a assays (Fig. 6 ) (ET-l > ET-3 > big ET), suggesting that the ET-I binding site defined in liver plasma membranes is correlated to activation ofglycogen phosphorylase a in isolated rat liver cells. There is up to two orders ofmagnitude difference between the apparent affinity of ET-1 for its binding sites and for activation of glycogen phosphorylase a. This apparent discrepancy has also been reported in liver for vasopressin and angiotensin II, which are 20-to 100-fold weaker for binding to their sites than for activating glycogen phosphorylase a (41, 42) . In other biological systems such a discrepancy has been already observed, for example, for vasopressin binding potency and antidiuretic response (43) . This is usually explained by the possible existence of a "receptor reserve". According to this hypothesis, there would be more ET-1 receptors in liver plasma membranes than are necessary to provoke a maximal, functional activation ofglycogenolysis. Therefore the maximal glycogenolytic response would be elicited only when a small fraction of ET-1 receptors are occupied. Moreover, the disparity between the potency of ET-l toward binding and glycogen phosphorylase a activation may also be explained by the poor reversibility of the ET-1 binding to its sites, which precludes the exact determination ofbinding parameters based on complete reversibility such as Kd values.
The presence of high affinity binding sites for ET-1 on hepatocytes raises the question as to the origin of ET-l which binds to liver plasma membranes. In vascular tissues, it has been shown that ET-1 is elaborated locally by endothelial cells adjacent to its target tissue, while it can also function as a circulating hormone (6) . Although most liver functions are performed in parenchymal cells, other cell types are also present in this organ, in particular endothelial and Kupffer cells. Recent studies have stressed the importance of interaction between liver parenchymal and nonparenchymal cells and suggested that activation of the liver vascular endothelial system results, through vasoconstriction, in localized anoxia and release of various mediators. In fact, PGD2, or other mediators produced by liver reticuloendothelial cells (44) , reportedly mediate stimulation ofglycogenolysis by phorbol esters (45) , platelet-activating factor (46) , and endotoxin (47) . Since a recent study indicates that endotoxin stimulates endothelin release in rat circulating blood (48), it is tempting to speculate that endothelin may be locally released by liver reticuloendothelial cells, and would then contribute to the stimulation of glycogenolysis by endotoxin.
The presence of high affinity and high capacity ET-l receptors in liver plasma membranes, associated with Ca2`mobilization and potent glycogenolytic effect in hepatocytes, in addition to significant amounts of ET-I -like immunoreactivity detected in liver (8) , are in favor of a local production of endothelin by liver reticuloendothelial cells. This possibility is now being explored in our laboratory.
